Adam H. Schechter - Feb 11, 2025 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role: President & CEO, Director
Signature: /s/ Sandra D. van der Vaart, Attorney-in-Fact for Adam H. Schechter
Stock symbol: LH
Transactions as of: Feb 11, 2025
Transactions value $: -$1,797,861
Form type: 4
Date filed: 2/13/2025, 11:49 AM
Previous filing: Feb 10, 2025
Next filing: Mar 18, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LH	Common Stock	Sale	-$1.5M	-6.12K	-6.61%	$244.62	86.4K	Feb 11, 2025	Direct	F1
transaction	LH	Common Stock	Options Exercise		+2.96K	+3.43%		89.4K	Feb 11, 2025	Direct	F2
transaction	LH	Common Stock	Tax liability	-$301K	-1.23K	-1.37%	$245.14	88.2K	Feb 11, 2025	Direct	F3

Showing 1 to 3 of 3 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LH	Non-qualified Stock Options	Award	$0	+33.1K		$0.00	33.1K	Feb 11, 2025	Common Stock	33.1K	$245.14	Direct	F4, F5
transaction	LH	Restricted Stock Unit	Award	$0	+11K	+72.5%	$0.00	26.1K	Feb 11, 2025	Common Stock	11K		Direct	F2, F6, F7
transaction	LH	Restricted Stock Unit	Options Exercise	$0	-2.96K	-11.35%	$0.00	23.1K	Feb 11, 2025	Common Stock	2.96K		Direct	F2, F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2	Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F3	Stock withholding to satisfy tax withholding obligations.
F4	Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
F5	The option vests in three equal annual installments beginning on the date reflected in this column.
F6	The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.
F7	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F8	The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.